Page 886 - Williams Hematology ( PDFDrive )

860 Part VI: The Erythrocyte Chapter 55: Alloimmune Hemolytic Disease of the Fetus and Newborn 861

90. Radunovic N, Lockwood CJ, Alvarez M, et al: The severely anemic and hydropic isoim- 113. Fasano R, Luban N: Blood component therapy for the neonate, in Fanaroff and Martin’s
mune fetus: Changes in fetal hematocrit associated with intrauterine death. Obstet Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant, edited by R Martin, A
Gynecol 79(3):390, 1992. Fanaroff, M Walsh, pp 1360–1374. Elsevier, St. Louis, MO, 2010.
91. Hallak M, Moise KJ Jr, Hesketh DE, et al: Intravascular transfusion of fetuses with rhe- 114. Patra K, et al: Adverse events associated with neonatal exchange transfusion in the
sus incompatibility: Prediction of fetal outcome by changes in umbilical venous pres- 1990s. J Pediatr 144(5):626, 2004.
sure. Obstet Gynecol 80(2):286, 1992. 115. Steiner LA, Storfer-Isser A, Siner B, et al: A decline in the frequency of neonatal
92. Wong E, Luban N: Intrauterine, neonatal, and pediatric transfusion, in Transfusion exchange transfusions and its effect on exchange-related morbidity and mortality. Pedi-
Therapy: Clinical Principles and Practice, edited by PD Mintz, p 159. AABB Press, atrics 120(1):27, 2007.
Bethesda, MD, 2005. 116. Fasano RM, Paul WM, Pisciotto PT: Complications of neonatal transfusion, in Trans-
93. Gibson BE, Todd A, Roberts I, et al: Transfusion guidelines for neonates and older fusion Reactions, edited by M Popovsky, pp 471–518. AABB Press, Bethesda, MD,
children. Br J Haematol 124(4):433, 2004. 2012.
94. Gonsoulin WJ, Moise KJ Jr, Milam JD, et al: Serial maternal blood donations for intra- 117. Jackson JC: Adverse events associated with exchange transfusion in healthy and ill new-
uterine transfusion. Obstet Gynecol 75(2):158, 1990. borns. Pediatrics 99(5):E7, 1997.
95. Nicolaides KH, Clewell WH, Rodeck CH: Measurement of human fetoplacental blood 118. Tan KL, Lim GC, Boey KW: Phototherapy for ABO haemolytic hyperbilirubinaemia.
volume in erythroblastosis fetalis. Am J Obstet Gynecol 157(1):50, 1987. Biol Neonate 61(6):358, 1992.
96. Hoogeveen M, Meerman RH, Pasman S, Egberts J: A new method to determine the 119. Ebbesen F: Evaluation of the indications for early exchange transfusion in rhesus hae-
feto-placental volume based on dilution of fetal haemoglobin and an estimation of molytic disease during phototherapy. Eur J Pediatr 133(1):37, 1980.
plasma fluid loss after intrauterine intravascular transfusion. BJOG 109(10):1132, 2002. 120. Smits-Wintjens VE, Walther FJ, Rath ME, et al: Intravenous immunoglobulin in
97. Giannina G, Moise KJ Jr, Dorman K: A simple method to estimate volume for fetal neonates with rhesus hemolytic disease: A randomized controlled trial. Pediatrics
intravascular transfusions. Fetal Diagn Ther 13(2):94, 1998. 127(4):680, 2011.
98. Van Kamp IL, Klumper FJ, Oepkes D, et al: Complications of intrauterine intravascular 121. Ovaly F: Late anaemia in Rh haemolytic disease. Arch Dis Child Fetal Neonatal Ed
transfusion for fetal anemia due to maternal red-cell alloimmunization. Am J Obstet 88(5):F444; author reply F445, 2003.
Gynecol 192(1):171, 2005. 122. Dhodapkar KM, Blei F: Treatment of hemolytic disease of the newborn caused by
99. Schonewille H, Klumper FJ, van de Watering LM, et al: High additional maternal red anti-Kell antibody with recombinant erythropoietin. J Pediatr Hematol Oncol 23(1):69,
cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfu- 2001.
sions for hemolytic disease of the fetus. Am J Obstet Gynecol 196(2):143.e1, 2007. 123. Zuppa AA, Alighieri G, Calabrese V, et al: Recombinant human erythropoietin in the
100. Ruma MS, Moise KJ Jr, Kim E, et al: Combined plasmapheresis and intravenous prevention of late anemia in intrauterine transfused neonates with Rh-isoimmuniza-
immune globulin for the treatment of severe maternal red cell alloimmunization. Am J tion. J Pediatr Hematol Oncol 32(3):e95, 2010.
Obstet Gynecol 196(2):138.e1, 2007. 124. McPherson RJ, Juul SE: Erythropoietin for infants with hypoxic-ischemic encephalop-
101. Collinet P, Subtil D, Puech F, Vaast P: Successful treatment of extremely severe fetal athy. Curr Opin Pediatr 22(2):139, 2010.
anemia due to Kell alloimmunization. Obstet Gynecol 100(5 Pt 2):1102, 2002. 125. Lindenburg IT, Smits-Wintjens VE, van Klink JM, et al: Long-term neurodevelopmen-
102. Dinesh D: Review of positive direct antiglobulin tests found on cord blood sampling. J tal outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn:
Paediatr Child Health 41(9–10):504, 2005. the LOTUS study. Am J Obstet Gynecol 206(2):141 e1, 2012.
103. Heddle NM, Wentworth P, Anderson DR, et al: Three examples of Rh haemolytic disease 126. Ip S, Chung M, Kulig J, et al: An evidence-based review of important issues concerning
of the newborn with a negative direct antiglobulin test. Transfus Med 5(2):113, 1995. neonatal hyperbilirubinemia. Pediatrics 114(1):e130, 2004.
104. Herschel M, Karrison T, Wen M, et al: Isoimmunization is unlikely to be the cause of 127. Newman TB, Liljestrand P, Jeremy RJ, et al: Outcomes among newborns with total
hemolysis in ABO-incompatible but direct antiglobulin test-negative neonates. Pediat- serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med 354(18):1889,
rics 110(1 Pt 1):127, 2002. 2006.
105. van Kamp IL, Klumper FJ, Bakkum RS, et al: The severity of immune fetal hydrops is pre- 128. Moise KJ Jr: Overview of Rhesus (Rh) alloimmunization in pregnancy. UpToDate 2014.
dictive of fetal outcome after intrauterine treatment. Am J Obstet Gynecol 185(3):668, 2001. http://www.uptodate.com/contents/overview-of-rhesus-rh-alloimmunization-in-
106. De Boer IP, Zeestraten EC, Lopriore E, et al: Pediatric outcome in Rhesus hemolytic dis- pregnancy. Last accessed on June 20, 2014.
ease treated with and without intrauterine transfusion. Am J Obstet Gynecol 198(1):54. 129. American College of Obstetrics and Gynecology: ACOG Practice Bulletin, Preven-
e1, 2008. tion of Rh(D) Alloimmunization, Number 4, 1999. Clinical Management Guidelines
107. Harper DC, Swingle HM, Weiner CP, et al: Long-term neurodevelopmental outcome for Obstetricians and Gynecologists. http://www.acog.org/goto/PBListOfTitles.aspx
and brain volume after treatment for hydrops fetalis by in utero intravascular transfu- (accessed on 29 May 2015).
sion. Am J Obstet Gynecol 195(1):192, 2006. 130. National Institutes for Health and Clinical Excellence: Pregnancy (Rhesus Negative
108. Ramasethu J: Exchange transfusions, in Atlas of Procedures in Neonatology, edited by Women) Routine Anti-D Review: Final Appraisal Determination, 2008. Available from:
M MacDonald, J Ramasethu, K. Rais-Bahrami, pp 315–323. Lippincott, Williams & http://www.nice.org.uk/guidance/ta156/documents/pregnancy-rhesus-negative-wom-
Wilkins, Philadelphia, 2013. en-routine-antid-review-final-appraisal-determination2. Last accessed on May 29, 2015.
109. Murray NA, Roberts IA: Haemolytic disease of the newborn. Arch Dis Child Fetal Neo- 131. Ayache S, Herman JH: Prevention of D sensitization after mismatched transfusion of
natal Ed 92(2):F83, 2007. blood components: Toward optimal use of RhIG. Transfusion 48(9):1990, 2008.
110. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia: Management 132. Kleihauer E, Braun H, Betke K: [Demonstration of fetal hemoglobin in erythrocytes of
of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics a blood smear] [in German]. Klin Wochenschr 35(12):637, 1957.
114(1):297, 2004. 133. Ramsey G: Inaccurate doses of R immune globulin after Rh-incompatible fetomaternal
111. Maisels MJ, Watchko JF: Treatment of jaundice in low birthweight infants. Arch Dis hemorrhage: Survey of laboratory practice. Arch Pathol Lab Med 133(3):465, 2009.
Child Fetal Neonatal Ed 88(6):F459, 2003. 134. Moise KJ Jr, Argoti PS: Management and prevention of red cell alloimmunization in
112. Hulzebos CV, van Imhoff DE, Bos AF, et al: Usefulness of the bilirubin/albumin ratio pregnancy: A systematic review. Obstet Gynecol 120(5):1132, 2012.
for predicting bilirubin-induced neurotoxicity in premature infants. Arch Dis Child 135. Moise KJ Jr: Management of rhesus alloimmunization in pregnancy. Obstet Gynecol
Fetal Neonatal Ed 93(5):F384, 2008. 100(3):600, 2002.

Kaushansky_chapter 55_p0847-0862.indd 861 9/18/15 11:53 PM